drugset / Trial / NCT01361776

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

NCT01361776 ↗

Phase 2/3 Completed 200 enrolled Sormland County Council, Sweden
RandomizedParallel-groupOpen-labelPrevention

Summary

Antibody titers after tick-borne encephalitis (TBE) vaccination are less in elderly and vaccination breakthroughs are more common in this age group. This has prompted Swedish authorities to recommend an additional dose in the initial vaccination schedule (= 0+30+90 days instead of the usually recommended 0+30 days. The investigators intend to evaluate this regime.

Timeline

Start
2011-09
Primary completion
2013-12
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator FSME-immune Vaccine 0.5 ml Intramuscular